Search Results - "Gates, Gregory A"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Eruptive Melanocytic Nevi in the Setting of Encorafenib, Cetuximab, and Binimetinib Combination Therapy: A Case Report by Lam, Karen, Gates, Gregory A., Bach, Daniel Q., Cheng, Kyle

    Published in Case reports in dermatology (01-01-2024)
    “…Abstract Introduction: The development of new and changing melanocytic lesions has been increasingly reported as an adverse dermatologic toxicity of BRAF…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Pulse Granulomas of the Gastrointestinal Tract and Gallbladder: Report of Five Cases by DeRoche, Tom C., Huber, Aaron R., Gates, Gregory A.

    Published in Case reports in pathology (01-01-2017)
    “…Hyaline rings with admixed multinucleated giant cells characterize pulse granulomas; the term pulse refers to edible seeds of legume vegetables. The etiology…”
    Get full text
    Journal Article
  4. 4

    Kikuchi–Fujimoto Disease With Unusual Cutaneous Findings by Gates, Gregory A., Li, Yunfeng, Magyar, Clara, Sarantopoulos, G. Peter

    Published in The American journal of dermatopathology (01-12-2021)
    “…We present a case of the rare Kikuchi-Fujimoto disease (KFD) in a 14-year-old patient admitted to UCLA Medical Center with fever, weight loss, and…”
    Get full text
    Journal Article
  5. 5

    Rare Case Report of Pilomatrical Carcinosarcoma in a Pediatric Patient by Gates, Gregory A., Nguyen, Johnny, Binder, Scott W.

    Published in The American journal of dermatopathology (01-03-2020)
    “…We present a case report of the exceptionally rare pilomatrical carcinosarcoma in an even rarer pediatric age group, a 9-year-old female patient. The tumor…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Eruptive Melanocytic Nevi in the Setting of Encorafenib, Cetuximab, and Binimetinib Combination Therapy: A Case Report by Lam, Karen, Gates, Gregory A, Bach, Daniel Q, Cheng, Kyle

    Published in Case reports in dermatology (01-01-2024)
    “…IntroductionThe development of new and changing melanocytic lesions has been increasingly reported as an adverse dermatologic toxicity of BRAF inhibitor…”
    Get full text
    Report
  8. 8
  9. 9